Recombinant Human EEF2K Protein，His

EEF2K (Eukaryotic Elongation Factor 2 Kinase) is a crucial enzyme that functions as a key regulator of protein synthesis by phosphorylating eukaryotic elongation factor 2 (eEF2), ultimately inhibiting translation and thereby affecting cellular growth and proliferation. Research into EEF2K has gained significant attention due to its involvement in various physiological and pathological processes, including stress responses, cancer development, and neurodegenerative diseases. Under conditions of cellular stress, EEF2K is activated, leading to a decrease in protein synthesis which conserves energy and resources, and helps cells adapt to adverse conditions. The role of EEF2K in cancer biology is particularly noteworthy, as its overexpression is often associated with enhanced tumor growth and resistance to chemotherapy, making it a potential target for therapeutic intervention. In addition, EEF2K's regulatory functions extend to various signaling pathways, including those related to mTOR and p53, which are critical for maintaining cellular homeostasis. However, the precise mechanisms governing EEF2K’s activity and its interactions with other molecular players in these pathways remain to be thoroughly elucidated. Consequently, ongoing studies focus on characterizing EEF2K's structure and function, exploring its potential as a biomarker for disease, and developing small molecules or inhibitors that can modulate its activity for therapeutic purposes. The growing body of evidence underscores the significance of EEF2K in both basic biological research and clinical applications, paving the way for future investigations into its role in health and disease.